Journal of Crohn’s and Colitis – Page 2 – Communicable Diseases Research

Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn’s Disease: Results from the Phase 2 Open-Label Extension Study

Original Article

Published on 2021-12-022024-09-04
Journal: Journal of Crohn's and Colitis [Category] 대상포진,

[키워드] Crohn’s disease long-term safety Open-label extension
[DOI] 10.1093/ecco-jcc/jjab093 PMC 바로가기 [Article Type] Original Article

Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials

Original Article

Published on 2021-11-212024-09-04
Journal: Journal of Crohn's and Colitis [Category] 대상포진,

[키워드] re-treatment Tofacitinib ulcerative colitis
[DOI] 10.1093/ecco-jcc/jjab065 PMC 바로가기 [Article Type] Original Article

Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study

Original Article

Published on 2021-07-132024-09-04
Journal: Journal of Crohn's and Colitis [Category] 대상포진,

[키워드] clinical trial Ozanimod ulcerative colitis
[DOI] 10.1093/ecco-jcc/jjab012 PMC 바로가기 [Article Type] Original Article

Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial

Original Article

Published on 2021-07-082024-09-04
Journal: Journal of Crohn's and Colitis [Category] 대상포진,

[키워드] Dose Adjustment maintenance Tofacitinib
[DOI] 10.1093/ecco-jcc/jjaa249 PMC 바로가기 [Article Type] Original Article

Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study

Original Article

Published on 2021-06-212024-09-04
Journal: Journal of Crohn's and Colitis [Category] 대상포진,

[키워드] etrasimod Long-term extension study ulcerative colitis
[DOI] 10.1093/ecco-jcc/jjab016 PMC 바로가기 [Article Type] Original Article

OP23 Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study

Oral presentations

Published on 2021-05-272024-09-04
Journal: Journal of Crohn's and Colitis [Category] 대상포진,

[DOI] 10.1093/ecco-jcc/jjab075.022 PMC 바로가기 [Article Type] Oral presentations

Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis

Original Article

Published on 2021-04-012024-09-04
Journal: Journal of Crohn's and Colitis [Category] 대상포진,

[키워드] experimental colitis IBD Janus kinase inhibitor Tyrosine kinase 2 inhibitor
[DOI] 10.1093/ecco-jcc/jjaa199 PMC 바로가기 [Article Type] Original Article

The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions

Original Article

Published on 2021-03-102024-09-04
Journal: Journal of Crohn's and Colitis [Category] 대상포진,

[키워드] epithelial cells IBD Jak-STAT Macrophage permeability TCPTP tight junction
[DOI] 10.1093/ecco-jcc/jjaa182 PMC 바로가기 [Article Type] Original Article

A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn’s Disease in Remission

다양한 식이 패턴은 관해 중인 크론병 환자에서 파에칼리박테리움과 대장균/시겔라의 균형 잡힌 장내 미생물 조성과 관련이 있다.

Article

Published on 2020-11-072024-08-22
Journal: Journal of Crohn's and Colitis [Category] 세균성이질,

Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease

Supplement Article

Published on 2020-08-112024-09-04
Journal: Journal of Crohn's and Colitis [Category] 대상포진,

[키워드] inflammatory bowel diseases Janus kinase inhibitors Janus kinases Signal transducer and activator of transcription
[DOI] 10.1093/ecco-jcc/jjaa014 PMC 바로가기 [Article Type] Supplement Article